SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-017558
Filing Date
2020-09-10
Accepted
2020-09-10 16:01:14
Documents
79
Period of Report
2020-07-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 537450
2 ex31-1.htm EX-31.1 12164
3 ex31-2.htm EX-31.2 12170
4 ex32-1.htm EX-32.1 4266
5 ex32-2.htm EX-32.2 4156
6 image_001.jpg GRAPHIC 18613
  Complete submission text file 0001493152-20-017558.txt   4083820

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE adxs-20200731.xml EX-101.INS 791209
8 XBRL SCHEMA FILE adxs-20200731.xsd EX-101.SCH 52583
9 XBRL CALCULATION FILE adxs-20200731_cal.xml EX-101.CAL 77258
10 XBRL DEFINITION FILE adxs-20200731_def.xml EX-101.DEF 154326
11 XBRL LABEL FILE adxs-20200731_lab.xml EX-101.LAB 355650
12 XBRL PRESENTATION FILE adxs-20200731_pre.xml EX-101.PRE 275285
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 201168749
SIC: 2834 Pharmaceutical Preparations